Search results for "Rigaku Analytical Devices"

25

Refine your search

Explore by Field
Browse by Techniques

Search

Selected Filters:



Editorial Article

Maximize success in biotherapeutic antibody development

Discover the key strategies and technologies for successful lead optimization in translational medicine, empowering your biotherapeutic antibody development with robust data and de-risking the path to clinical advancement










Resolution ctDx FIRST Assay

Agilent Technologies

Agilent Resolution ctDx FIRST is a liquid biopsy NGS assay optimized for cancer genomic profiling. ctDx FIRST is an FDA approved companion diagnostic to KRAZATI™ (adagrasib) for the detection of KRAS G12C in non-small cell lung cancer (NSCLC) and provides tumor mutation profiling for single nucleotide variants (SNVs) and deletions in the EGFR gene.

0.0/5.0
|0 Reviews
  • Best New Clinical Assay or Kit of the Year
Request Pricing